United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-317_2b781a00-5b89-4dff-9294-e97854165efb
Product NDC
71205-317
Form
CAPSULE
Composition / generic term
Gabapentin
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20180514
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE, PLASTIC (71205-317-30) · 71205-317-30
  • 60 CAPSULE in 1 BOTTLE, PLASTIC (71205-317-60) · 71205-317-60
  • 90 CAPSULE in 1 BOTTLE, PLASTIC (71205-317-90) · 71205-317-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Gabapentin — United States | Molindra Medicines